FindTrial
Sign In

Professional Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in children with Type 1 Diabetes Mellitus

Professional Continuous Glucose Monitoring and self monitoring of blood glucose in children with Type 1 Diabetes Mellitus: an Open Label Randomized Control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007937
Enrollment
70
Registered
2017-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type 1 Diabetes Mellitus

Interventions

Intervention1: Professional Continous Glucose montoring (CGM) by a device for 3-5days PLUS Self monitoring of Blood Glucose (SMBG) by glucometer: Treatment is guided/modified by result of Professional

Sponsors

PGIMER Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children with a diagnosis of Type 1 DM for at least 6 month 2. Age between 2 to 10 years. 3. Patients on basal-bolus regimen with insulin analogues with 3-4 injections per day and doing SMBG at least 3-4 times per day.

Exclusion criteria

Exclusion criteria: 1. Children with history of acute metabolic decompensation such as DKA within previous 2 months. 2. Children on chronic medications known to affect blood glucose such as systemic corticosteroids. 3. Patients with known poor compliance and HbA1c >12%.

Design outcomes

Primary

MeasureTime frame
Unit Change in HbA1c valuesTimepoint: 3 months post intervention—

Secondary

MeasureTime frame
Frequency of Low and high blood sugar recordsTimepoint: 3 months post treatment—

Countries

India

Contacts

Public ContactDr Rakesh Kumar

PGIMER,, Chandigarh

kvravitheja@gmail.com91-8195862345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026